* BIO-Key International Inc BKYI.OQ BKYI.O is expected
to show
a rise in quarterly revenue when it reports results on May 15.
* The Wall New Jersey New Jersey-based company is expected
to
report a 3.0% increase in revenue to $2 million from $1.94
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for BIO-Key
International Inc
is for a loss of 27 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts had fallen by
about 237.5% in the last three months.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $2, above its last closing price
of $0.67.
This summary was machine generated May 13 at 02:02 GMT. All
figures in US dollars unless otherwise stated